Global Biosimulation Market

In this age of advanced technology, we strive to find answers for how to preemptively know the reaction which a test drug can have with another medicine as well as a body without testing it on humans. Biosimulation is the technology which surfaced as a result of research on this idealization. It can provide information about drug-drug interaction on a molecular level, precision concerning dosage as well as physiologically-based pharmacokinetic (PBPK). Mathematical predictions of drug interactions with body and other drugs are gaining massive popularity in drug discovery and early development of drugs. With the use of biosimulation, the in vivo effects, efficacy, and safety which were hard to predict earlier even after identification of molecular machinery is now predicted efficiently. Thus, with the introduction of biosimulation, a discipline known as Pharmaceutical Toxicology is surfacing. With the help of biosimulation, it has become easier to understand, predict and manage the possible risks and hazards associated with agents used to treat human diseases. This process involves a complete study of biological, chemical and pharmaceutical aspects of agents thereby, making it easier to pinpoint the issues in a comparatively efficient way.

Market Dynamics

Since biosimulation makes it possible to study molecular interactions, it becomes easier to implement personalized medicinal practices effectively. This factor also acts as the primary driver of the market. Furthermore, with increasing interest was shown by researchers and funding bodies in this field ensures more development which is considered as another significant factor to encourage the growth of the market. Moreover, with an increase in cases of chronic diseases and multimorbidity, biosimulation can fuel the research to find efficient solutions for dealing with the same, thereby, gaining the significant attention of funding bodies. This will, therefore, add to the growth of the market. With the advent of improved simulation and modeling tools, biosimulation can further be enhanced to provide more detailed and accurate results along with an easy understanding of the technology. This can result in increased awareness and therefore may contribute towards market growth. Another significant factor impacting the growth of the market is the overall growth of the pharmaceutical and biotechnological industries, thus fueling the underlying technologies.

Market Segmentation

The primary segmentation categories for biosimulation market include product based, application based, end-user based and geography based. Product based segmentation provides software and services. Both groups are further subdivided. Software includes PK/PD Modeling and Simulation software, PBPK Modeling and Simulation software, Molecular Modeling and Simulation software, Toxicity Prediction, Trial Design and others. Services are divided into In-house and external/contract based. By application market can be divided into, drug development (preclinical testing, clinical trials), drug discovery (lead and target identification and optimization) and other applications. By end user, we can segment market as Academic and government institutions, Pharmaceutical and Biotechnology companies, contract research organizations and other users. North America, Europe, Asia-Pacific and the Middle East and Africa form the geography wise segmentation.

Geographical Analysis

Because of enormous adoption of biosimulation technologies, North America leads the market followed by Europe. Currently, Asia-Pacific remains untapped, but, because of growth in the economy and improved healthcare spending, it is expected to snowball.

Key Players

Some of the major players in the market include Certara Inc., Simulation Plus Inc., Chemical Computing Group, DassaultSystemes, Physiomics PLC and Rhenovia Pharma Ltd.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage